arabinofuranosylcytosine triphosphate has been researched along with phosphatidylcholines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dave, C; Mayhew, E; Papahadjopoulos, D; Rustum, YM | 1 |
| Berkovic, D; Breass, J; Fleer, EA; Hiddemann, W; Pförtner, J; Schleyer, E | 1 |
2 other study(ies) available for arabinofuranosylcytosine triphosphate and phosphatidylcholines
| Article | Year |
|---|---|
Use of liposomes for the enhancement of the cytotoxic effects of cytosine arabinoside.
Topics: Animals; Arabinofuranosylcytosine Triphosphate; Cytarabine; Drug Synergism; Female; Leukemia L1210; Liposomes; Mice; Mice, Inbred DBA; Pharmaceutical Vehicles; Phosphatidylcholines; Phosphatidylserines; Pregnancy; Tissue Distribution | 1978 |
The influence of 1-beta-D-arabinofuranosylcytosine on the metabolism of phosphatidylcholine in human leukemic HL 60 and Raji cells.
Topics: Antimetabolites, Antineoplastic; Arabinofuranosylcytosine Triphosphate; Cell Survival; Cytarabine; HL-60 Cells; Humans; Lysophosphatidylcholines; Phosphatidylcholines | 1997 |